Drug List Changes

  • Effective April 01, 2021

    Formulary Changes to the Preferred B4 Drug List

    Drug Name Description of Change Cost-effective Alternatives*
    Atripla tabletMoving to Tier 3efavirenz/emtricitabine/tenofovir disoproxil tablet
    Banzel suspensionMoving to Tier 3rufinamide suspension
    Truvada 200 mg-300 mg tabletMoving to Tier 3emtricitabine/tenofovir disoproxil 200 mg-300 mg tablet

    Formulary Changes to the E4 Drug List

    Drug Name Description of Change Cost-effective Alternatives*
    Symfi tabletMoving to Tier 4efavirenz/lamivudine/tenofovir disoproxil tablet
    Symfi Lo tabletMoving to Tier 4efavirenz/lamivudine/tenofovir disoproxil tablet
    Tecfidera delayed-release capsuleMoving to Tier 4dimethyl fumarate delayed-release capsule
    Truvada 200 mg-300 mg tabletMoving to Tier 4emtricitabine/tenofovir disoproxil 200 mg-300 mg tablet

    *These drugs have been selected by an independent group of experts made up of doctors and pharmacists. This group reviews drugs to see how well they work relative to their cost. They also compare their effectiveness to similar drugs used to treat the same condition. Please talk with your doctor to see if these new options are right for you.